RxDoctor Payments Data

Ricardo Rodriguez Aponte, MD

Family Medicine · Aibonito, PRNPI 1457526758

Payments from drug & device makers

$698in general payments, 2019–2025

Across 37 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$192
  • Johnson & Johnson$101
  • Abbott$100
  • Boehringer Ingelheim$71
  • Sanofi-aventis U.S. LLC$48
  • GSK$42
  • plus $143 from 5 others

What the payments were for

  • Food & beverage$698100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$698 in reported general payments places this provider in the 70th percentile of 497 family medicine providers in Puerto Rico.

See all family medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$13,742
Medicare patients
46
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban462$277,021
SynthroidLevothyroxine Sodium2,452$125,627
GlyxambiEmpagliflozin/Linagliptin109$101,866
BrilintaTicagrelor127$62,334
FarxigaDapagliflozin Propanediol85$56,786
JardianceEmpagliflozin65$47,189
TradjentaLinagliptin45$38,179
XareltoRivaroxaban59$36,060
Jentadueto XrLinagliptin/Metformin Hcl39$36,059
Humulin NInsulin Nph Human Isophane262$31,042
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate105$28,592
SynjardyEmpagliflozin/Metformin Hcl26$19,259
Trijardy XrEmpaglifloz/Linaglip/Metformin17$17,635
Arnuity ElliptaFluticasone Furoate66$17,629
Breo ElliptaFluticasone/Vilanterol42$17,307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimGlyxambi, Jardiance, Tradjenta, Jentadueto Xr, Synjardy$71$276,470316 claims
AstraZenecaBrilinta, Farxiga$192$119,120212 claims
Johnson & JohnsonXarelto$101$36,06059 claims
GSKArnuity Ellipta, Breo Ellipta$42$34,936108 claims
Sanofi-aventis U.S. LLCLantus$48$9,32581 claims
MerckJanumet$38$9,12714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 497 family medicine providers in Puerto Rico.

Other family medicine in Aibonito

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →